Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BlackRock Health Sciences Term TrustBMEZ · Entity 4922 | Portfolio Manager | January 30, 2026 | February 03, 2026 |
| BlackRock Health Sciences TrustBME · Entity 8913 | Portfolio Manager | January 30, 2026 | February 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BlackRock Health Sciences Term Trust
Report date January 30, 2026 · Filed February 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-01-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-01-30 · Exercise / conversion · Acquired 777.9221 · Balance 777.9221 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Row 2 · 2026-01-30 · Disposition to issuer · Disposed 777.9221 · Balance 0 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 1,026.693 |
Reported balance
After 2026-01-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-30 · Grant · Acquired 1,026.693 · Balance 1,026.693 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4: These phantom shares vest in equal installments on each of the first three anniversaries of the award. |
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 1,046.6621 |
Reported balance
After 2026-01-30 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-30 · Exercise / conversion · Disposed 523.331 · Balance 1,046.6621 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 254.5911 |
Reported balance
After 2026-01-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-30 · Exercise / conversion · Disposed 254.5911 · Balance 254.5911 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F4: These phantom shares vest in equal installments on each of the first three anniversaries of the award.
BlackRock Health Sciences Trust
Report date January 30, 2026 · Filed February 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-01-30 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-01-30 · Exercise / conversion · Acquired 389.1035 · Balance 389.1035 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F4: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Row 2 · 2026-01-30 · Disposition to issuer · Disposed 389.1035 · Balance 0 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F4: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 372.9639 |
Reported balance
After 2026-01-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-30 · Grant · Acquired 372.9639 · Balance 372.9639 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F5: These phantom shares vest in equal installments on each of the first three anniversaries of the award. |
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 405.2066 |
Reported balance
After 2026-01-30 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-30 · Exercise / conversion · Disposed 202.6033 · Balance 405.2066 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 86.5745 |
Reported balance
After 2026-01-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-30 · Exercise / conversion · Disposed 86.5745 · Balance 86.5745 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
| Phantom SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-01-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-30 · Exercise / conversion · Disposed 99.9257 · Balance 0 F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
F2: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F3: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F4: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
F5: These phantom shares vest in equal installments on each of the first three anniversaries of the award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2026 Filed Feb 3, 2026 17:35 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | Exercise / conversionPhantom Shares · Derivative | 254.5911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-035933 · ownership.xml · derivative · entry 5 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254.5911 Underlying: Common Stock · 254.5911 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:35 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | Exercise / conversionPhantom Shares · Derivative | 523.331 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-035933 · ownership.xml · derivative · entry 4 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046.6621 Underlying: Common Stock · 523.331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:35 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | GrantPhantom Shares · Derivative | 1,026.693 | $15.21 | $15,616.00 |
DisclosureSEC source: 0001193125-26-035933 · ownership.xml · derivative · entry 3 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,026.693 Underlying: Common Stock · 1,026.693 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:35 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | Disposition to issuerCommon Stock | 777.9221 | $15.21 | $11,832.20 |
DisclosureSEC source: 0001193125-26-035933 · ownership.xml · nonDerivative · entry 2 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:35 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | Exercise / conversionCommon Stock | 777.9221 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-035933 · ownership.xml · nonDerivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 777.9221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:00 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 99.9257 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-035818 · ownership.xml · derivative · entry 6 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 99.9257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:00 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 86.5745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-035818 · ownership.xml · derivative · entry 5 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86.5745 Underlying: Common Stock · 86.5745 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:00 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 202.6033 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-035818 · ownership.xml · derivative · entry 4 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405.2066 Underlying: Common Stock · 202.6033 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:00 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | GrantPhantom Shares · Derivative | 372.9639 | $41.87 | $15,616.00 |
DisclosureSEC source: 0001193125-26-035818 · ownership.xml · derivative · entry 3 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372.9639 Underlying: Common Stock · 372.9639 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F5 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F5 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F5 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:00 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Disposition to issuerCommon Stock | 389.1035 | $41.87 | $16,291.76 |
DisclosureSEC source: 0001193125-26-035818 · ownership.xml · nonDerivative · entry 2 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F4 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 17:00 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionCommon Stock | 389.1035 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-035818 · ownership.xml · nonDerivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389.1035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 4, 2025, the Reporting Person was granted phantom shares on January 31, 2025 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F4 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:24 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 109.3669 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-013494 · ownership.xml · derivative · entry 6 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109.3669 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:24 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 91.9724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-013494 · ownership.xml · derivative · entry 5 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91.9724 Underlying: Common Stock · 91.9724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:24 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 79.6839 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-013494 · ownership.xml · derivative · entry 4 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159.3678 Underlying: Common Stock · 79.6839 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:24 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | GrantPhantom Shares · Derivative | 559.433 | $40.92 | $22,892.00 |
DisclosureSEC source: 0000950170-25-013494 · ownership.xml · derivative · entry 3 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559.433 Underlying: Common Stock · 559.433 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F5 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F5 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F5 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:24 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Disposition to issuerCommon Stock | 281.0232 | $40.92 | $11,499.47 |
DisclosureSEC source: 0000950170-25-013494 · ownership.xml · nonDerivative · entry 2 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F4 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:24 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionCommon Stock | 281.0232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-013494 · ownership.xml · nonDerivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281.0232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F4 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 15:27 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | Exercise / conversionPhantom Shares · Derivative | 225.1171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-013270 · ownership.xml · derivative · entry 4 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450.2342 Underlying: Common Stock · 225.1171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 15:27 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | GrantPhantom Shares · Derivative | 1,388.2353 | $16.49 | $22,892.00 |
DisclosureSEC source: 0000950170-25-013270 · ownership.xml · derivative · entry 3 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388.2353 Underlying: Common Stock · 1,388.2353 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 15:27 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | Disposition to issuerCommon Stock | 225.1171 | $16.49 | $3,712.18 |
DisclosureSEC source: 0000950170-25-013270 · ownership.xml · nonDerivative · entry 2 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 15:27 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | Exercise / conversionCommon Stock | 225.1171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-013270 · ownership.xml · nonDerivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225.1171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 19:33 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 102.4022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010819 · ownership.xml · derivative · entry 5 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102.4022 Underlying: Common Stock · 102.4022 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 19:33 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 86.1154 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010819 · ownership.xml · derivative · entry 4 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172.2309 Underlying: Common Stock · 86.1154 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 19:33 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | GrantPhantom Shares · Derivative | 223.8284 | $41.48 | $9,284.40 |
DisclosureSEC source: 0000950170-24-010819 · ownership.xml · derivative · entry 3 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223.8284 Underlying: Common Stock · 223.8284 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F4 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 19:33 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Disposition to issuerCommon Stock | 188.5176 | $41.48 | $7,819.71 |
DisclosureSEC source: 0000950170-24-010819 · ownership.xml · nonDerivative · entry 2 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 19:33 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionCommon Stock | 188.5176 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-010819 · ownership.xml · nonDerivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188.5176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F3 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 17:31 UTC | BlackRock Health Sciences Term Trust BMEZ · Entity 4922 | GrantPhantom Shares · Derivative | 517.8137 | $17.93 | $9,284.40 |
DisclosureSEC source: 0000950170-24-010665 · ownership.xml · derivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 517.8137 Underlying: Common Stock · 517.8137 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 19:03 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionPhantom Shares · Derivative | 96.1138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-003670 · doc4.xml · derivative · entry 4 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192.2276 Underlying: Common Stock · 96.1138 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 19:03 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | GrantPhantom Shares · Derivative | 242.4816 | $43.56 | $10,562.50 |
DisclosureSEC source: 0000899243-23-003670 · doc4.xml · derivative · entry 3 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242.4816 Underlying: Common Stock · 242.4816 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F3 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 19:03 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Disposition to issuerCommon Stock | 96.1138 | $43.56 | $4,186.72 |
DisclosureSEC source: 0000899243-23-003670 · doc4.xml · nonDerivative · entry 2 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 19:03 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | Exercise / conversionCommon Stock | 96.1138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-003670 · doc4.xml · nonDerivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96.1138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · price: As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:30 UTC | BlackRock Health Sciences Trust BME · Entity 8913 | GrantPhantom Shares · Derivative | 271.6186 | $45.10 | $12,250.00 |
DisclosureSEC source: 0000899243-22-004280 · doc4.xml · derivative · entry 1 Liu Xiang · CIK 0001815485 · Portfolio Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271.6186 Underlying: Common Stock · 271.6186 shares Expires not disclosed F1 · derivative.exercise_price: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_price: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.exercise_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.exercise_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. F1 · derivative.expiration_date: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash. F2 · derivative.expiration_date: These phantom shares vest in equal installments on each of the first three anniversaries of the award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.